Subscribe & Stay Informed

Subscribe today for free and stay on top of latest news in food industry

    Close Menu
    Food Infotech
      Facebook YouTube LinkedIn
      Food Infotech
      • Home
      • Processing
      • Packaging
      • Logistics
      • Safety
      • Articles
      • Events
      • Jobs
      • More
        • E-Mag
        • Subscription
        • Newsletter
      Facebook YouTube LinkedIn WhatsApp
      Food Infotech
      Home»News

      HMO Producer Jennewein to be brought for €310 million by Chr. Hansen

      Shashank GauravBy Shashank GauravSeptember 23, 2020Updated:September 23, 20203 Mins Read
      Share
      Facebook Twitter LinkedIn WhatsApp

      Chr. Hansen has stepped into the human milk oligosaccharides (HMO) market by signing an agreement to buy Jennewein Biotechnologie at a price of 310m Euros.

      The transaction comprises of all the shares of the international industrial biotechnology company and is in accordance with Chr. Hansen’s 2025 action plan of pursuing this deal that extend and boost its microbial and fermentation technology platforms.

      According to Chr. Hansen, useful ingredients such as HMOs and probiotics are running the premiumisation trends in infant formulations.

      Jennewein, hsving its headquarters in Bonn, Germany manufactures several HMO products like 2′ fucosyllactose, Lacto-N-neotetraose, and lacto-N-tetraose. The company has around 100 staffs, a worldly customer base and an IP portfolio of more than 200 patents granted in major markets.

      Chr. Hansen claims that Jennewein’s products will have impregnable functional concurrence with its probiotic bacteria and amalgamating the companies will lead to an even more stronger competitive benefits.

      Following the agreement, Chr. Hansen decides to invest more than €200 million in manufacturing assets till 2025, including an investment in a brown-field factory to broaden its HMO capacity.

      “The tremendously-developing HMO market is a new space that we have been focussing with incredible interest for some years. In truth, we are making a long-haul investment and commitment to HMOs which I am convinced, will bring incessant value creation to our shareholders,” Mauricio Graber, CEO of Chr. Hansen declared.

      He further informed- “For us, Jennewein is a strong fit to our microbial portfolio, as its fermentation platform is also upgradable and provides good long-haul margin potential as volumes rises. Jennewein is a leader in the HMO industry with a best product offering and IP portfolio, and we have faith that the company holds a prime position in this relatively new and very delightful market.”

      Dr Stefan Jennewein, founder and CEO of Jennewein declared- “While initially we were very much fascinated by the anti-infective impacts of HMOs, especially against human pathogenic viruses, today we are clear that some more advantages can be hoped from the combination of HMOs with probiotics. Thus, Chr. Hansen is the perfect partner for Jennewein to take the HMO story to the next level of betterment.”

      After the completion of this transaction by the end of this month, Jennewein will take upon the role as chief science and technology advisor. The HMO business will partner with Chr. Hansen’s health & nutrition unit and will function as an independent, full value chain.

      CHR Hansen Jennewein Takeover
      Share. Facebook Twitter LinkedIn WhatsApp
      Shashank Gaurav

      More article from Shashank Gaurav

      Keep Reading

      JENI’S Launches Ice Cream Bars Nationwide

      NutriFusion Honored as Bronze Stevie Award Winner in 2025 American Business Awards

      Genetically Modified Food Safety Testing Market to Reach 24.21 USD Billion by 2034 with 6.3% CAGR

      Leave A Reply Cancel Reply

      PROCESSING

      Bühler Integrates NapaRoast Technology

      May 12, 2025

      Bühler Launches World’s First Inductively Heated Wafer Oven—OptiBake

      May 9, 2025

      Nestlé Unlocks Premium Cold Coffee Innovation

      May 9, 2025

      Lohiya Group Inaugurates Biscuit Manufacturing Facility in Telangana

      May 6, 2025

      PACKAGING

      Sidel and Saudi Arabia Sign Agreement

      The MoU was signed by Eng. Saleh AlSolami, CEO of the Saudi National Industrial Development…

      SÜDPACK Appoints Thorsten Seehars as New CEO

      SÜDPACK appoints Thorsten Seehars as new CEO. He succeeds Erik Bouts, who successfully led the…

      Amcor Partnership With Metsä Group

      Amcor, a global leader in developing and producing responsible packaging solutions, and forestry industry company…

      © 2025 FOODINFOTECH.COM.
      • Home
      • About Us
      • Terms of Service
      • Privacy Policy
      • Contact Us

      Type above and press Enter to search. Press Esc to cancel.